-

IMS Shin-Matsudo Central General Hospital Completes First Patient Treatment with the ZAP-X Gyroscopic Radiosurgery Platform

Installation Marks the Third ZAP-X System in Japan to Offer the Latest Advance in Non-Surgical Brain Tumor Care

SHINMATSUDO, Japan--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a leading innovator in the field of surgical robotics, today announced that IMS Shin-Matsudo Central General Hospital, located in the heart of Shinmatsudo, Chiba, Japan, recently completed its inaugural patient treatment utilizing the cutting-edge ZAP-X® Gyroscopic Radiosurgery® platform.

Strategically located approximately 25 miles northeast of Tokyo, IMS Shin-Matsudo Central General Hospital stands as a center of medical excellence within the region. As part of the IMS private hospital group, a network of approximately 140 hospitals, clinics, and nursing homes, the newly established Shin Matsudo Accuracy Radiation Therapy (SMART) center is committed to pushing the boundaries of advanced medical care. Leveraging ZAP-X’s groundbreaking vault-free capability, the system now resides on the building’s second floor, and is poised to transform the landscape of radiosurgery treatments.

Stereotactic radiosurgery (SRS) provides a non-invasive option for treating many primary and metastatic brain tumors, as well as other conditions of the head and neck. Notably, SRS has shown equivalent to superior outcomes compared to traditional open surgery. Involving only one to five brief outpatient visits, SRS often allows patients to resume normal activities on the same day as the procedure.

“The introduction of the ZAP-X platform represents a paradigm shift in our approach to radiosurgical care,” said Jun Itami, MD, PhD, Radiation Oncologist, and Director of the SMART Center. "This installation marks the third ZAP-X platform in Japan, and further reaffirms our commitment to pioneering medical advancements.”

Central to its innovation, the ZAP-X system unveils a ground-breaking gyroscopic design capable of guiding radiosurgical beams from thousands of potential unique angles to an exact focal point of high-dose radiation delivery to the targeted tumor. This pioneering approach ideally supports the clinical imperative of minimizing collateral damage to healthy brain tissue and preserving patient cognitive function.

ZAP-X also stands out as the first and only vault-free SRS delivery system, doing away with the necessity for healthcare providers to construct expensive shielded radiation treatment rooms. And by employing a contemporary linear accelerator for radiation generation, ZAP-X is also the first and only dedicated cranial radiosurgery system that no longer relies on Cobalt-60 radioactive sources, thereby eliminating the substantial expenses and efforts associated with hosting, securing, and regularly replacing radioactive isotopes.

About ZAP Surgical Systems, Inc.

ZAP Surgical Systems, Inc. designs and manufactures the ZAP-X® Gyroscopic Radiosurgery® platform. ZAP was founded in 2014 by Dr. John R. Adler. In addition to being CEO of ZAP, Dr. Adler is Emeritus Dorothy & TK Chan Professor of Neurosurgery and Radiation Oncology at Stanford University. Dr. Adler is also renowned as the inventor of the CyberKnife® system and founder of Accuray, Inc. The ZAP-X platform incorporates a unique vault-free design that typically eliminates the need for costly shielded treatment rooms. ZAP-X also utilizes a modern linear accelerator to eliminate legacy use of Cobalt-60. Learn more at ZAP Surgical and follow us on LinkedIn.

Contacts

Mark Arnold, ZAP Surgical Systems, Inc.
Senior Vice President, Marketing
+1 650 492 7797, ext. 101
Email: info@zapsurgical.com

ZAP Surgical Systems, Inc.


Release Versions

Contacts

Mark Arnold, ZAP Surgical Systems, Inc.
Senior Vice President, Marketing
+1 650 492 7797, ext. 101
Email: info@zapsurgical.com

Social Media Profiles
More News From ZAP Surgical Systems, Inc.

ZAP Surgical Unveils the ZAP-Axon® Radiosurgery Planning System

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the ZAP-Axon® Radiosurgery Planning System*, an entirely new software platform dedicated to the company’s ZAP-X® Gyroscopic Radiosurgery® system. Designed to simplify, accelerate, and enhance treatment planning, Axon aims to set new benchmarks in world-class radiosurgery brain tumor treatments. Axon is currently pending FDA 510(k) clearance and is expected to b...

ZAP Surgical Secures $78M in Series E Funding Led by Baheal Medical

SAN CARLOS, Calif.--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced the successful closing of a $78 million Series E funding round led by Qingdao Baheal Medical Inc., with participation from other strategic investors. The new financing will advance the commercialization of the Company’s pioneering ZAP-X® Gyroscopic Radiosurgery® platform. Stereotactic radiosurgery (SRS) is a well-established procedure for the non-invasive treat...

Dongguk University Ilsan Hospital Completes First Brain Tumor Treatments with the ZAP-X Gyroscopic Radiosurgery Platform

GOYANG-SI, South Korea--(BUSINESS WIRE)--ZAP Surgical Systems, Inc., a global leader in surgical robotics, proudly announces the completion of first patient treatments at Dongguk University Ilsan Hospital using the ZAP-X® Gyroscopic Radiosurgery® platform. This marks the second installation of the ZAP-X system in Korea, signifying a substantial advancement in providing cutting-edge medical care to patients in the Asia-Pacific region. Stereotactic radiosurgery (SRS) provides a non-invasive and p...
Back to Newsroom